Green Thumb Industries is projected to report Q2 2026 revenue of $348.2 million and an EPS of $0.06, with the stock currently trading at $12.30 against an average analyst price target of $20.40. Investors are primarily focused on Adjusted EBITDA margins as a measure of operational efficiency in a maturing market.
Positive sentiment is driven by the successful rollout of adult-use sales in Ohio and the company's industry-leading cash flow position. Analysts are also looking for updates on tax strategy adjustments following the anticipated reclassification of cannabis to Schedule III, which could significantly reduce the company's effective tax rate.